Document is current
Any future updates will be listed below
-
Authors
Huang, Allan Shuai
Chin, Hui San
Reljic, Boris
Djajawi, Tirta M.
Tan, Iris K. L.
Gong, Jia-Nan
Stroud, David A. http://orcid.org/0000-0002-2048-3383
Huang, David C. S. http://orcid.org/0000-0002-3101-4873
van Delft, Mark F. http://orcid.org/0000-0002-3866-4318
Dewson, Grant http://orcid.org/0000-0003-4251-8898
-
Funding
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (1140851)
Bodhi Education Foundation
- License Information
-
More Information
Article History
Received: 3 May 2022
Revised: 11 September 2022
Accepted: 13 September 2022
First Online: 28 September 2022
Competing interests
: GD, DCSH and MvD are employees of the Walter and Eliza Hall Institute which receives royalty payments relating to the use of Venclexta/venetoclax.
: This study did not include human participants or animal research and so did not require ethics approval.
